{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:04:12Z","timestamp":1789844652730,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.vhri.2026.101665","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:54:06Z","timestamp":1782856446000},"page":"101665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-Effectiveness of Vaccine for the Prevention of Herpes Zoster in Kidney Transplant Recipients in Thailand"],"prefix":"10.1016","volume":"57","author":[{"given":"Teerapon","family":"Dhippayom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyameth","family":"Dilokthornsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Yeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackrapong","family":"Bruminhent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sancy A.","family":"Leachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathorn","family":"Chaiyakunapruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vhri.2026.101665_bib1","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","article-title":"A systematic literature review of herpes zoster incidence worldwide","volume":"17","author":"van Oorschot","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vhri.2026.101665_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2344983","article-title":"A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific","volume":"20","author":"Chen","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vhri.2026.101665_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/j.pain.0000000000001718","article-title":"Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition","volume":"161","author":"Harvey","year":"2020","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.vhri.2026.101665_bib4","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s40121-024-01002-4","article-title":"The incidence of herpes zoster complications: a systematic literature review","volume":"13","author":"Giannelos","year":"2024","journal-title":"Infect Dis Ther"},{"issue":"45","key":"10.1016\/j.vhri.2026.101665_bib5","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1016\/j.vaccine.2018.08.080","article-title":"Cost of herpes zoster and herpes zoster-related complications among immunocompromised individuals","volume":"36","author":"Meyers","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vhri.2026.101665_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.978203","article-title":"Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: a systematic review and network meta-analysis","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vhri.2026.101665_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13696998.2021.2008195","article-title":"Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence","volume":"25","author":"Udayachalerm","year":"2022","journal-title":"J Med Econ"},{"issue":"7","key":"10.1016\/j.vhri.2026.101665_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2016.08.720","article-title":"Cost-utility analysis of herpes zoster vaccine in Thailand","volume":"19","author":"Taychakhoonavudh","year":"2016","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.vhri.2026.101665_bib9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s41669-023-00438-7","article-title":"Cost-effectiveness of recombinant zoster vaccine for the prevention of herpes zoster in hematopoietic stem cell transplant recipients and other immunocompromised adults in the United States","volume":"7","author":"Salem","year":"2023","journal-title":"Pharmacoecon Open"},{"issue":"7","key":"10.1016\/j.vhri.2026.101665_bib10","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1093\/cid\/ciz1090","article-title":"Herpes zoster risk in immunocompromised adults in the United States: A systematic review","volume":"71","author":"McKay","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vhri.2026.101665_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13674","article-title":"Incidence of herpes zoster in adult solid organ transplant recipients: a meta-analysis and comprehensive review","volume":"23","author":"Kwon","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.vhri.2026.101665_bib12","series-title":"Annual Report on Organ Transplantation in Thailand 2022","year":"2022"},{"key":"10.1016\/j.vhri.2026.101665_bib13","series-title":"Guideline for Health Technology Assessment in Thailand Updated Edition 2021","year":"2019"},{"issue":"6","key":"10.1016\/j.vhri.2026.101665_bib14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jval.2012.06.012","article-title":"Modeling good research practices\u2014overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20141","volume":"15","author":"Caro","year":"2012","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.vhri.2026.101665_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40258-021-00704-x","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"20","author":"Husereau","year":"2022","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"10.1016\/j.vhri.2026.101665_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jamainternmed.2017.7431","article-title":"Cost-effectiveness of the adjuvanted herpes zoster subunit vaccine in older adults","volume":"178","author":"Le","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.vhri.2026.101665_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12879-015-1038-1","article-title":"Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis","volume":"15","author":"Pavlopoulou","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.vhri.2026.101665_bib18","first-page":"381","article-title":"Prevalence and outcome of disseminated Varicella zoster infection post kidney transplantation","volume":"99","author":"Chitasombat","year":"2016","journal-title":"J Med Assoc Thai"},{"issue":"3","key":"10.1016\/j.vhri.2026.101665_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/nep.12378","article-title":"A 25-year experience of kidney transplantation in Thailand: report from the Thai Transplant Registry","volume":"20","author":"Noppakun","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"10.1016\/j.vhri.2026.101665_bib20","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.bbmt.2017.01.013","article-title":"A phase III, double-blind, randomized, placebo-controlled, multicenter clinical trial to study the safety, tolerability, efficacy, and immunogenicity of inactivated Vzv vaccine (ZVIN) in recipients of autologous hematopoietic cell transplants (auto-Hcts)","volume":"23","author":"Winston","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.vhri.2026.101665_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313889","article-title":"Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations","volume":"19","author":"Marra","year":"2024","journal-title":"PLOS One"},{"issue":"2","key":"10.1016\/j.vhri.2026.101665_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.vhri.2026.101665_bib24","series-title":"Standard Cost Lists for Health Technology Assessment","author":"Riewpaiboon","year":"2009"},{"issue":"Suppl 5","key":"10.1016\/j.vhri.2026.101665_bib25","first-page":"S127","article-title":"Standard cost lists for health economic evaluation in Thailand","volume":"97","author":"Riewpaiboon","year":"2014","journal-title":"J Med Assoc Thai"},{"issue":"9","key":"10.1016\/j.vhri.2026.101665_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001307","article-title":"A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments","volume":"9","author":"Wyld","year":"2012","journal-title":"PLOS Med"},{"issue":"1","key":"10.1016\/j.vhri.2026.101665_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan\u2014Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"10.1016\/j.vhri.2026.101665_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008123","article-title":"Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand","volume":"5","author":"Nimdet","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.vhri.2026.101665_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/ajt.14683","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines","volume":"18","author":"Dooling","year":"2018","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.vhri.2026.101665_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged\u2265 19 years: recommendations of the Advisory Committee on Immunization Practices-United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:47:13Z","timestamp":1789843633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926000804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":29,"alternative-id":["S2212109926000804"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101665","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Vaccine for the Prevention of Herpes Zoster in Kidney Transplant Recipients in Thailand","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101665"}}